手法を比較
選択した手法を並べて確認できます。異なる行はハイライト表示されます。
| ベイズ経路富化解析× | マルチオミクスパスウェイエンリッチメント解析× | |
|---|---|---|
| 分野 | バイオインフォマティクス | バイオインフォマティクス |
| 系統 | Process / pipeline | Process / pipeline |
| 提唱年≠ | 2001–2007 | 2014–2016 (multi-omics extension of enrichment methods established ~2005) |
| 提唱者≠ | Pierre Baldi, Anthony Long; Michael Newton et al. (foundational Bayesian gene-set frameworks) | Building on Subramanian et al. (2005); multi-omics integration formalised by Meng et al. and others (~2014–2016) |
| 種類≠ | Probabilistic gene-set testing | Integrative pathway analysis pipeline |
| 原典≠ | Baldi, P., & Long, A. D. (2001). A Bayesian framework for the analysis of microarray expression data: regularized t-test and statistical inferences of gene changes. Bioinformatics, 17(6), 509–519. DOI ↗ | Meng, C., Kuster, B., Culhane, A. C., & Gholami, A. M. (2014). A multivariate approach to the integration of multi-omics datasets. BMC Bioinformatics, 15, 162. link ↗ |
| 別名 | Bayesian gene-set testing, Bayesian GSEA, Bayesian functional enrichment, BGSEA | multi-omics pathway analysis, integrated pathway enrichment, multi-layer pathway enrichment, MOPEA |
| 関連≠ | 6 | 1 |
| 概要≠ | Bayesian pathway enrichment analysis tests whether a predefined set of genes — a biological pathway — is systematically overrepresented among genes that show evidence of differential activity in an experiment. Unlike classical over-representation tests, it encodes prior biological knowledge as a prior distribution and updates it with the observed expression data, yielding posterior probabilities of enrichment rather than p-values. This probabilistic framing naturally handles small samples, multiple pathways, and uncertainty propagation in a coherent statistical framework. | Multi-omics pathway enrichment analysis is a bioinformatics pipeline that integrates molecular data from two or more omics layers — such as transcriptomics, proteomics, metabolomics, and epigenomics — and tests whether the combined signal from those layers converges on specific biological pathways more than expected by chance. By considering multiple molecular levels simultaneously, it identifies pathway-level dysregulation that single-omics analyses would miss. |
| ScholarGateデータセット ↗ |
|
|